495 related articles for article (PubMed ID: 17091471)
21. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
22. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
[TBL] [Abstract][Full Text] [Related]
23. Alternative transcriptional initiation and splicing define the translational efficiencies of zebrafish mRNAs encoding eukaryotic initiation factor 4E.
Fahrenkrug SC; Joshi B; Hackett PB; Jagus R
Differentiation; 2000 Aug; 66(1):15-22. PubMed ID: 10997588
[TBL] [Abstract][Full Text] [Related]
24. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.
Siegele B; Cefalu C; Holm N; Sun G; Tubbs J; Meschonat C; Odaka Y; DeBenedetti A; Ghali GE; Chu Q; Mathis JM; Li BD
J Surg Res; 2008 Jul; 148(1):83-9. PubMed ID: 18570935
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
[TBL] [Abstract][Full Text] [Related]
26. Potyvirus terminal protein VPg, effector of host eukaryotic initiation factor eIF4E.
Grzela R; Strokovska L; Andrieu JP; Dublet B; Zagorski W; Chroboczek J
Biochimie; 2006 Jul; 88(7):887-96. PubMed ID: 16626853
[TBL] [Abstract][Full Text] [Related]
27. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
Sorrells DL; Meschonat C; Black D; Li BD
J Surg Res; 1999 Jul; 85(1):37-42. PubMed ID: 10383835
[TBL] [Abstract][Full Text] [Related]
28. A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides.
Friedland DE; Wooten WN; LaVoy JE; Hagedorn CH; Goss DJ
Biochemistry; 2005 Mar; 44(11):4546-50. PubMed ID: 15766285
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of plant eIF4E-mediated resistance against a Carmovirus (Tombusviridae): cap-independent translation of a viral RNA controlled in cis by an (a)virulence determinant.
Truniger V; Nieto C; González-Ibeas D; Aranda M
Plant J; 2008 Dec; 56(5):716-27. PubMed ID: 18643998
[TBL] [Abstract][Full Text] [Related]
30. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
31. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis.
Zimmer SG; DeBenedetti A; Graff JR
Anticancer Res; 2000; 20(3A):1343-51. PubMed ID: 10928042
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
[TBL] [Abstract][Full Text] [Related]
33. Stabilizing the eIF4G1 α-helix increases its binding affinity with eIF4E: implications for peptidomimetic design strategies.
Brown CJ; Lim JJ; Leonard T; Lim HC; Chia CS; Verma CS; Lane DP
J Mol Biol; 2011 Jan; 405(3):736-53. PubMed ID: 21094167
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of the translation initiation factor eIF4E in differentiating epithelial lung tumor cell lines.
Walsh D; Meleady P; Power B; Morley SJ; Clynes M
Differentiation; 2003 Mar; 71(2):126-34. PubMed ID: 12641566
[TBL] [Abstract][Full Text] [Related]
35. eIF-4E expression and its role in malignancies and metastases.
De Benedetti A; Graff JR
Oncogene; 2004 Apr; 23(18):3189-99. PubMed ID: 15094768
[TBL] [Abstract][Full Text] [Related]
36. Dual regulation of translation initiation and peptide chain elongation during BDNF-induced LTP in vivo: evidence for compartment-specific translation control.
Kanhema T; Dagestad G; Panja D; Tiron A; Messaoudi E; Håvik B; Ying SW; Nairn AC; Sonenberg N; Bramham CR
J Neurochem; 2006 Dec; 99(5):1328-37. PubMed ID: 17064361
[TBL] [Abstract][Full Text] [Related]
37. Influence of the length of the phosphate chain in mRNA 5' cap analogues on their interaction with eukaryotic initiation factor 4E.
Zuberek J; Jemielity J; Niedzwiecka A; Stepinski J; Wyslouch-Cieszynska A; Stolarski R; Darzynkiewicz E
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1707-10. PubMed ID: 14565501
[TBL] [Abstract][Full Text] [Related]
38. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas.
Nathan CO; Carter P; Liu L; Li BD; Abreo F; Tudor A; Zimmer SG; De Benedetti A
Oncogene; 1997 Aug; 15(9):1087-94. PubMed ID: 9285563
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation states of translational initiation factors affect mRNA cap binding in wheat.
Khan MA; Goss DJ
Biochemistry; 2004 Jul; 43(28):9092-7. PubMed ID: 15248766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
